Kevin Winardi is a scientific officer in the Laboratory of Ageing and Pharmacology led by Prof Sarah Hilmer at the Kolling Institute, operating in partnership with the University of Sydney and the Northern Sydney Local Health District. His work integrates systems biology, pharmacology, and biogerontology to understand drug response and its impact to organ function in the context of ageing. He applies proteomics and systems pharmacology approaches to better delineate the molecular complexity of multiple medication usage (polypharmacy), drug-induced harms, and medication cessation (deprescribing). His long-term goal is to advance precision prescribing and improve medication safety practices for older adults through translational ageing research.

Lorna is a first-year house officer at Christchurch Hospital and a final-year PhD candidate at the University of Otago, Christchurch. Her doctoral research leverages medical informatics to integrate electronic prescribing data from MedChart with siloed hospital datasets to quantify and improve appropriate medicine use. Her research to date has utilised large-scale clinical data to evaluate indications for medicine use, polypharmacy in the hospital setting, and antithrombotic therapy following ischemic stroke. Lorna is a member of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and her research has been recognised with a Graduate Women New Zealand Fellowship.

Professor Shakib is Professor of Clinical Pharmacology at the University of Adelaide. His main research interest is in polypharmacy and new models of care for multimorbidity management.

Monica (PhD BPharm(Hons) BSci) is a clinical pharmacist at Alfred Health and a Postdoctoral Researcher at the Monash Addiction Research Centre, Faculty of Medicine, Nursing and Health Sciences, Monash University. Her research focuses on improving the safe and effective use of medicines, with a particular emphasis on deprescribing high-risk psychotropic medicines such as opioids and benzodiazepines. Monica’s doctoral thesis provided some of the first real-world evidence on opioid tapering trajectories in Australian primary care, providing novel insights to inform clinical practice and guidelines. Monica completed the Graduate Entry Pharmacy program and her PhD at Monash University, following a Bachelor of Science in Biochemistry at the University of Rochester, New York. Monica’s work integrates clinical practice and implementation research, aiming to support safer medication use and improved patient outcomes across healthcare settings.

Aisling is a PhD candidate from the Centre for Medicine Use and Safety at Monash University. Her research focuses on deprescribing benzodiazepine receptor agonists in people living with dementia. She is excited to find non-pharmacological approaches to assist with sleep as a replacement for benzodiazepines and z-drugs. Before starting as a PhD student, Aisling completed her BPharm and MPharm with Monash University. Aisling continues to work as a clinical pharmacist at The Alfred Hospital while completing her PhD.